AS Bravo Pharmaceuticals
- Registry code
- 14159974
- VAT number
- EE101938974
- Address
- Harju maakond, Viimsi vald, Haabneeme alevik, Paadi tee 3, 74001
- Registered
- 29.11.2016 · 9 yrs
- Activity
- Muud mujal liigitamata tervishoiualad 8699
- Capital
- 163 137 €
- r•••@b•••.inLog in to see
- Phone
- +372 5•• ••••Log in to see
- Website
- www.bppl.co.in from email
Business Register 05.10.2026
Annual report 2025 not filed, deadline was 30.06.2026
Sales revenue28 873 €+45%2024 annual report
Profit-71 167 €2024 annual report
Employees2Tax Board 2026 Q2
Average gross salary302 €estimate, Tax Board 2026 Q2
Labour taxes per quarter923 €Tax Board 2026 Q2
Cash75 €Cash 31.12.2024, annual report
Tax debt0 €Tax Board debtor list 05.10.2026
State taxes 12 months5 662 €Tax Board, last 4 quarters
Quick check
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- No bankruptcy or liquidation
- No sanctions
- Report filed (2024)
- VAT registered
Stability
Follow companyNotification when something changesRatingBBB → BB → BBB
In tax debt0 days since 26.09.2026
Revenue 12 months▼ 100% vs a year earlier
Add the rating badge to your website
The badge code is available to this company's verified account: verification uses a code we send to the company email in the Business Register. The badge updates itself and cannot be bought. Read more
Board and owners
3 persons
| Board 2 | ||
|---|---|---|
| Rakesh Pandey3 companies2 with tax debt | Personal ID ↗ | 29.11.2016 |
| Reena Singh1 companyno tax debt | Personal ID ↗ | 21.12.2018 |
| Other persons 1 | ||
| Nasdaq CSD SE1983 companies155 with tax debt40 bankruptShare register keeper | Personal ID ↗ | 02.01.2018 |
| Beneficial owners 2 | ||
| Rakesh Pandey3 companies2 with tax debtdirect holding | 11.08.2019 | |
| Reena Singh1 companyno tax debtdirect holding | 11.08.2019 | |
Business Register open data
Quarterly taxes and revenue
2026 Q2
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2026 Q2 | 0 € | 923 € | 877 € | 2 | |
| 2026 Q1 | 0 € | 2 826 € | 3 042 € | 2 | |
| 2025 Q4 | 0 € | — | — | 1 | |
| 2025 Q3 | 0 € | 1 651 € | 1 743 € | 1 | |
| 2025 Q2 | 0 € | 5 656 € | 6 288 € | 1 | |
| 2025 Q1 | 3 443 € | ▼ 68% | 2 901 € | 4 324 € | 1 |
| 2024 Q4 | 5 421 € | ▼ 63% | 4 025 € | 4 683 € | 1 |
| 2024 Q3 | 0 € | 4 571 € | 5 223 € | 1 | |
| 2024 Q2 | 17 100 € | 4 844 € | 7 415 € | 1 | |
| 2024 Q1 | 10 674 € | 4 791 € | 7 013 € | 1 | |
| 2023 Q4 | 14 557 € | 4 685 € | 7 123 € | 1 | |
| 2023 Q3 | 0 € | 5 697 € | 6 808 € | 1 |
Show full history (18 quarters)
| 2023 Q2 | 0 € | 3 637 € | 4 141 € | 1 | |
| 2023 Q1 | 0 € | 4 591 € | 5 485 € | 1 | |
| 2022 Q4 | 0 € | 4 614 € | 5 519 € | 1 | |
| 2022 Q3 | 0 € | 4 574 € | 5 376 € | 1 | |
| 2022 Q2 | 4 000 € | 4 574 € | 5 377 € | 1 | |
| 2022 Q1 | 15 775 € | 4 574 € | 5 453 € | 1 |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
4 yr
| 2024 | 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|---|
| Sales revenue | 28 873 € | ▲ 45% | 19 945 € | ▲ 318% | 4 775 € | ▼ 84% | 30 158 € |
| Profit | -71 167 € | ▲ 16% | -85 212 € | ▲ 15% | -100 k € | ▼ 75% | -57 313 € |
| Profit margin | -246,5% | -427,2% | -2096,8% | -190,0% | |||
| Retained earnings | -226 k € | ▼ 61% | -141 k € | ▼ 246% | -40 649 € | ▼ into loss | 16 664 € |
| Cash | 75 € | ▲ 14% | 66 € | ▲ 14% | 58 € | ▼ 99% | 5 045 € |
| Current assets | 46 661 € | ▼ 19% | 57 561 € | ▲ 1% | 56 781 € | ▼ 9% | 62 375 € |
| Fixed assets | 238 k € | ▼ 1% | 242 k € | ▼ 4% | 251 k € | ▼ 6% | 267 k € |
| Assets | 285 k € | ▼ 5% | 299 k € | ▼ 3% | 307 k € | ▼ 7% | 329 k € |
| Current liabilities | 243 k € | ▲ 30% | 186 k € | ▲ 70% | 109 k € | ▼ 24% | 144 k € |
| Long-term liabilities | — | 0 € | 0 € | 0 € | |||
| Total liabilities | 243 k € | ▲ 30% | 186 k € | ▲ 70% | 109 k € | ▼ 24% | 144 k € |
| Equity | 41 787 € | ▼ 63% | 113 k € | ▼ 43% | 198 k € | ▲ 7% | 185 k € |
| Labour costs | -33 308 € | ▼ 6% | -31 526 € | ▼ 3% | -30 462 € | 0% | -30 462 € |
| Employees | 2 | 0% | 2 | 0% | 2 | 0% | 2 |
| Filed | 28.07.2025 | 08.07.2024 | 26.09.2023 | 21.06.2022 | |||
| Report | PDF ↓ | PDF ↓ | PDF ↓ | PDF ↓ |
▲ growth, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2024
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Muud mujal liigitamata tervishoiualad main activity | 8699 | 28 873 € | 100% |
2024 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
No tax debt · Tax Board 05.10.2026
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
clean
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
none
No transactions with state agencies, procurement contracts or grants found
RTK Saldo, Riigihangete register, RTK toetatud projektid
Holdings in other companies
0
No holdings in other companies
Companies linked via the board
60
AS AlexelaNasdaq CSD SE555,0 m €BBEricsson Eesti AktsiaseltsNasdaq CSD SE416,6 m €AAAS SEB PankNasdaq CSD SE405,8 m €AAAktsiaselts METAPRINTNasdaq CSD SE85,8 m €AAAAS HANZA Mechanics TartuNasdaq CSD SE81,5 m €AAAERGO Insurance SENasdaq CSD SE80,6 m €AAAElke Tallinn ASNasdaq CSD SE62,0 m €AAAaktsiaselts ESTIKO - PLASTARNasdaq CSD SE48,2 m €AAAStockmann AktsiaseltsNasdaq CSD SE42,3 m €AAaktsiaselts PINUSNasdaq CSD SE29,6 m €AAAAktsiaselts BalbiinoNasdaq CSD SE29,5 m €AAAAktsiaselts Magnum VeterinaariaNasdaq CSD SE28,6 m €BBAktsiaselts KROONINGNasdaq CSD SE27,1 m €BInterchemie Werken De Adelaar Eesti aktsiaseltsNasdaq CSD SE25,5 m €BBBSchneider Electric Eesti ASNasdaq CSD SE24,9 m €BAktsiaselts TopautoNasdaq CSD SE21,6 m €AAAktsiaselts Lincona KonsultNasdaq CSD SE19,2 m €AAAAS All Media EestiNasdaq CSD SE17,2 m €AAAktsiaselts PAFERNasdaq CSD SE15,1 m €AAABaltyre Eesti ASNasdaq CSD SE14,8 m €AAAaktsiaselts PristisNasdaq CSD SE13,5 m €AAAAktsiaselts Viru ElektrikaubandusNasdaq CSD SE10,6 m €AAAktsiaselts STANDARDNasdaq CSD SE10,6 m €AAS Eesti LeivatööstusNasdaq CSD SE10,3 m €Aaktsiaselts LTTNasdaq CSD SE10,2 m €AAAMotoral Eesti AktsiaseltsNasdaq CSD SE8,6 m €AAktsiaselts Silmani ElekterNasdaq CSD SE8,0 m €Aaktsiaselts HALS TRADING - TNasdaq CSD SE6,8 m €Aaktsiaselts "Rauameister"Nasdaq CSD SE6,8 m €AAAktsiaselts "Erimell"Nasdaq CSD SE6,4 m €AAAAktsiaselts Taastusravikeskus ViikingNasdaq CSD SE5,8 m €AAAAktsiaselts Loo ElekterNasdaq CSD SE5,5 m €AAAaktsiaselts IKODORNasdaq CSD SE4,9 m €AAAktsiaselts ANTAARESNasdaq CSD SE4,7 m €AACaverion Eesti ASNasdaq CSD SE4,6 m €AAktsiaselts Kiviõli KaubahoovNasdaq CSD SE4,4 m €AAAktsiaselts Metsaküla PiimNasdaq CSD SE3,9 m €AAAaktsiaselts VÕRU VESINasdaq CSD SE3,4 m €AAAaktsiaselts TAUF-AUTONasdaq CSD SE2,9 m €AAAaktsiaselts CISTANasdaq CSD SE2,6 m €AAAPRIMULATOR EESTI AktsiaseltsNasdaq CSD SE2,2 m €AAARTT AktsiaseltsNasdaq CSD SE2,1 m €AAAAS Remedium Kalamaja ApteekNasdaq CSD SE1,7 m €AAaktsiaselts ESTIKONasdaq CSD SE1,6 m €AAAAktsiaselts Ekspress GruppNasdaq CSD SE1,4 m €AALEKON PROPERTY ASNasdaq CSD SE1,2 m €AAAAktsiaselts FotoluksNasdaq CSD SE1,1 m €BBBAktsiaselts LAVEXNasdaq CSD SE692 k €CAktsiaselts Peipsi KalameesNasdaq CSD SE498 k €AAAktsiaselts MihkliNasdaq CSD SE475 k €AAAS Tolaram InvestmentsNasdaq CSD SE380 k €AAAktsiaselts Projekt ENasdaq CSD SE198 k €AAAktsiaselts YearNasdaq CSD SE132 k €CRaisio Eesti AktsiaseltsNasdaq CSD SE120 k €ADeden-Invest AktsiaseltsNasdaq CSD SE51 638 €AKatus ASNasdaq CSD SE13 588 €Aaktsiaselts FaabulaNasdaq CSD SE0 €BBBAktsiaselts TalveaedNasdaq CSD SE · Likvideerimisel0 €CAktsiaselts SpratfilNasdaq CSD SE · Bankrupt0 €CAktsiaselts RoolidNasdaq CSD SE0 €
Sorted by revenue (latest report or 4 quarters).
Top 20 in activity: Muud mujal liigitamata tervishoiualad
20
| # | Company | Revenue |
|---|---|---|
| 1 | Sihtasutus Tartu Kiirabi | 25,4 m € |
| 2 | Osaühing Corrigo | 3,8 m € |
| 3 | EU Micron OÜ | 2,9 m € |
| 4 | Kuuldeaparaadid OÜ | 1,8 m € |
| 5 | osaühing Mediserv | 1,1 m € |
| 6 | ST.PeReKe OÜ | 1,1 m € |
| 7 | Dermis Clinic OÜ | 423 k € |
| 8 | BACT OÜ | 281 k € |
| 9 | Jalaravi kabinet OÜ | 280 k € |
| 10 | Reakt Füsioteraapia OÜ | 230 k € |
| 11 | Academic Plastic Surgery OÜ | 171 k € |
| 12 | Levande OÜ | 158 k € |
| 13 | Methodraie OÜ | 157 k € |
| 14 | OÜ Suhtelabor | 118 k € |
| 15 | Töökeskkonna Haldus OÜ | 95 985 € |
| 16 | Medimic OÜ | 93 893 € |
| 17 | SILKDERM OÜ | 79 787 € |
| 18 | Lümfoloogia- ja Taastusravikeskus OÜ | 72 103 € |
| 19 | KI Therapy OÜ | 70 146 € |
| 20 | K-Tervishoid OÜ | 69 716 € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Domains
1 records
Domains
| Domain | Source |
|---|---|
| bppl.co.in |
History and notices
20
| Date | Type | Content |
|---|---|---|
| 11.09.2026 | Aruandetrahvimäärus | |
| 14.07.2026 | Trahvihoiatusmäärus: majandusaasta aruanne esitamata | |
| 15.07.2025 | Trahvihoiatusmäärus: majandusaasta aruanne esitamata | |
| 21.02.2025 | Entry | Amendment entry |
| 19.09.2024 | Entry | Amendment entry |
| 01.08.2024 | Order to remedy deficiencies | Amendment entry |
| 07.07.2024 | Trahvihoiatusmäärus: majandusaasta aruanne esitamata | |
| 25.02.2022 | Entry | Amendment entry |
| 07.02.2022 | Entry | Amendment entry |
| 22.07.2020 | Entry | Amendment entry |
| 21.12.2018 | Entry | Amendment entry |
| 19.01.2018 | Entry | Amendment entry |
| 02.01.2018 | Entry | Ümberkujundamiskanne |
| 13.12.2017 | Entry | Amendment entry |
| 13.12.2017 | Entry | Amendment entry |
| 12.12.2017 | Entry | Amendment entry |
| 12.12.2017 | Order to remedy deficiencies | Amendment entry |
| 28.09.2017 | Entry | Amendment entry |
| 21.01.2017 | Entry | Amendment entry |
| 29.11.2016 | Entry | First entry |